The Goldman Sachs Group, Inc. 13D and 13G filings for Oaktree Acquisition Corp. III Life Sciences:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-11 3:04 pm Purchase | 2026-03-31 | 13G | OAKTREE ACQUISITION CORP III OACC | GOLDMAN SACHS GROUP INC GS | 1,228,500 6.200% | 425,013 (+52.90%) | Filing |
| 2025-08-12 12:12 pm Sale | 2025-06-30 | 13G | OAKTREE ACQUISITION CORP III OACC | GOLDMAN SACHS GROUP INC GS | 803,487 4.100% | -534,015 (-39.93%) | Filing |
| 2025-05-09 12:31 pm Purchase | 2025-03-31 | 13G | OAKTREE ACQUISITION CORP III OACC | GOLDMAN SACHS GROUP INC GS | 1,337,502 6.700% | 1,337,502 (New Position) | Filing |